{
  "actions": [
    {
      "acted_at": "2017-10-06", 
      "action_code": "Intro-H", 
      "references": [], 
      "text": "Introduced in House", 
      "type": "action"
    }, 
    {
      "acted_at": "2017-10-06", 
      "action_code": "H11100", 
      "committees": [
        "HSIF"
      ], 
      "references": [], 
      "status": "REFERRED", 
      "text": "Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.", 
      "type": "referral"
    }, 
    {
      "acted_at": "2017-10-06", 
      "action_code": "H11100", 
      "committees": [
        "HSJU"
      ], 
      "references": [], 
      "text": "Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.", 
      "type": "referral"
    }, 
    {
      "acted_at": "2017-10-13", 
      "action_code": "", 
      "committees": [
        "HSIF"
      ], 
      "references": [], 
      "text": "Referred to the Subcommittee on Health.", 
      "type": "referral"
    }, 
    {
      "acted_at": "2017-10-16", 
      "action_code": "", 
      "committees": [
        "HSJU"
      ], 
      "references": [], 
      "text": "Referred to the Subcommittee on Crime, Terrorism, Homeland Security, and Investigations.", 
      "type": "referral"
    }
  ], 
  "amendments": [], 
  "bill_id": "hr3991-115", 
  "bill_type": "hr", 
  "by_request": false, 
  "committee_reports": [], 
  "committees": [
    {
      "activity": [
        "referral"
      ], 
      "committee": "House Judiciary", 
      "committee_id": "HSJU"
    }, 
    {
      "activity": [
        "referral"
      ], 
      "committee": "House Judiciary", 
      "committee_id": "HSJU", 
      "subcommittee": "Subcommittee on Crime, Terrorism, and Homeland Security", 
      "subcommittee_id": "08"
    }, 
    {
      "activity": [
        "referral"
      ], 
      "committee": "House Energy and Commerce", 
      "committee_id": "HSIF"
    }, 
    {
      "activity": [
        "referral"
      ], 
      "committee": "House Energy and Commerce", 
      "committee_id": "HSIF", 
      "subcommittee": "Subcommittee on Health", 
      "subcommittee_id": "14"
    }
  ], 
  "congress": "115", 
  "cosponsors": [
    {
      "bioguide_id": "C000984", 
      "district": "7", 
      "name": "Cummings, Elijah E.", 
      "original_cosponsor": false, 
      "sponsored_at": "2017-10-27", 
      "state": "MD", 
      "title": "Rep", 
      "withdrawn_at": null
    }
  ], 
  "enacted_as": null, 
  "history": {
    "active": false, 
    "awaiting_signature": false, 
    "enacted": false, 
    "vetoed": false
  }, 
  "introduced_at": "2017-10-06", 
  "number": "3991", 
  "official_title": "To amend section 303(g)(2) of the Controlled Substances Act to allow certain pharmacists to dispense narcotic drugs for maintenance or detoxification treatment pursuant to the same waiver provisions as apply with respect to nurse practitioners and physician assistants.", 
  "popular_title": null, 
  "related_bills": [], 
  "short_title": "Expanded Access to Opioid Abuse Treatment Act of 2017", 
  "sponsor": {
    "bioguide_id": "L000580", 
    "district": "1", 
    "name": "Lujan Grisham, Michelle", 
    "state": "NM", 
    "title": "Rep", 
    "type": "person"
  }, 
  "status": "REFERRED", 
  "status_at": "2017-10-06", 
  "subjects": [
    "Crime and law enforcement", 
    "Drug therapy", 
    "Drug trafficking and controlled substances", 
    "Drug, alcohol, tobacco use", 
    "Health personnel"
  ], 
  "subjects_top_term": "Crime and law enforcement", 
  "summary": {
    "as": "Introduced in House", 
    "date": "2017-10-06T04:00:00Z", 
    "text": "Expanded Access to Opioid Abuse Treatment Act of 2017\n\nThis bill amends the Controlled Substances Act to allow a pharmacist who meets specified criteria to be a qualifying practitioner who may administer, dispense, or prescribe narcotic drugs for maintenance or detoxification treatment in an office-based opioid treatment program."
  }, 
  "titles": [
    {
      "as": "introduced", 
      "is_for_portion": false, 
      "title": "To amend section 303(g)(2) of the Controlled Substances Act to allow certain pharmacists to dispense narcotic drugs for maintenance or detoxification treatment pursuant to the same waiver provisions as apply with respect to nurse practitioners and physician assistants.", 
      "type": "official"
    }, 
    {
      "as": "introduced", 
      "is_for_portion": false, 
      "title": "Expanded Access to Opioid Abuse Treatment Act of 2017", 
      "type": "short"
    }, 
    {
      "as": "introduced", 
      "is_for_portion": false, 
      "title": "Expanded Access to Opioid Abuse Treatment Act of 2017", 
      "type": "short"
    }, 
    {
      "as": null, 
      "is_for_portion": false, 
      "title": "Expanded Access to Opioid Abuse Treatment Act of 2017", 
      "type": "display"
    }
  ], 
  "updated_at": "2019-04-18T16:16:15Z", 
  "url": "https://www.govinfo.gov/bulkdata/BILLSTATUS/115/hr/BILLSTATUS-115hr3991.xml"
}